Before you sell to, join or invest in CERO THERAPEUTICS HOLDINGS, INC.
MentionFox check on CERO THERAPEUTICS HOLDINGS, INC.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/cero-therapeutics-holdings-inc-form-d-25000001
Check CERO THERAPEUTICS HOLDINGS, INC. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about CERO THERAPEUTICS HOLDINGS, INC.?
Based on the record MentionFox holds for this company. No flag is not a clearance.
CERO THERAPEUTICS HOLDINGS, INC. filed a Form D with the Securities and Exchange Commission on 2025-05-06.
CERO THERAPEUTICS HOLDINGS, INC. filed a Form D notice of an exempt securities offering with the SEC on May 6, 2025. The filing reports $5M sold. Its industry group is Pharmaceuticals. It names Chris Ehrlich (Chairman and Chief Executive Officer), Andrew Kucharchuk (Chief Financial Officer), Kristen Pierce (Chief Development Officer) (SEC Form D, May 6, 2025).
Is this your company?
Sell to companies like CERO THERAPEUTICS HOLDINGS, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-06 · the record
Pitching, partnering or investing alongside them? See who really runs and owns CERO THERAPEUTICS HOLDINGS, INC.
Free to see. No signup.
More on the people and the money behind CERO THERAPEUTICS HOLDINGS, INC., from the filings we hold.
Pharmaceuticals raises by companies based in California, filed within 90 days of this one, largest first.
Get an email when CERO THERAPEUTICS HOLDINGS, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when CERO THERAPEUTICS HOLDINGS, INC. raises, hires or launches. No email unless you switch it on.
Watch CERO THERAPEUTICS HOLDINGS, INC. →Get the full cited report on CERO THERAPEUTICS HOLDINGS, INC.
What the filing shows about CERO THERAPEUTICS HOLDINGS, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CERO THERAPEUTICS HOLDINGS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives CERO THERAPEUTICS HOLDINGS, INC.'s address as 201 Haskins Way, Suite 230, South San Francisco, CA 94080.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on CERO THERAPEUTICS HOLDINGS, INC. See pricing
CERO THERAPEUTICS HOLDINGS, INC. is a registered filer with the SEC (CIK 1870404) and has filed since 2024-02-23. 3 filings are on record, the latest on 2025-05-06.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
CERO THERAPEUTICS HOLDINGS, INC.'s Form D of 2025-05-06 names Chris Ehrlich, Andrew Kucharchuk, Kristen Pierce and 5 more as its officers, directors or promoters.
Its new offerings report $16.44M sold across 3 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 155 filings in Pharmaceuticals, totalled by week.
On the filing as: Executive Officer, Director.
Chris Ehrlich is named as Chairman and Chief Executive Officer on the Form D that CERO THERAPEUTICS HOLDINGS, INC. filed with the SEC on 6 May 2025, one of 8 people that filing names.
On the filing as: Executive Officer.
Andrew Kucharchuk is named as Chief Financial Officer on the Form D that CERO THERAPEUTICS HOLDINGS, INC. filed with the SEC on 6 May 2025, one of 8 people that filing names.
On the filing as: Executive Officer.
Kristen Pierce is named as Chief Development Officer on the Form D that CERO THERAPEUTICS HOLDINGS, INC. filed with the SEC on 6 May 2025, one of 8 people that filing names.
Brian Atwood is named as Director on the Form D that CERO THERAPEUTICS HOLDINGS, INC. filed with the SEC on 6 May 2025, one of 8 people that filing names.
Michael Byrnes is named as Director on the Form D that CERO THERAPEUTICS HOLDINGS, INC. filed with the SEC on 6 May 2025, one of 8 people that filing names.
Kathleen LaPorte is named as Director on the Form D that CERO THERAPEUTICS HOLDINGS, INC. filed with the SEC on 6 May 2025, one of 8 people that filing names.
Shami Patel is named as Director on the Form D that CERO THERAPEUTICS HOLDINGS, INC. filed with the SEC on 6 May 2025, one of 8 people that filing names.
Lindsey Rolfe is named as Director on the Form D that CERO THERAPEUTICS HOLDINGS, INC. filed with the SEC on 6 May 2025, one of 8 people that filing names.
8 people named on the filing — 3 holding an executive role and 5 as directors only.
Named as of the 2025-05-06 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about CERO THERAPEUTICS HOLDINGS, INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CERO THERAPEUTICS HOLDINGS, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CERO THERAPEUTICS HOLDINGS, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist CERO THERAPEUTICS HOLDINGS, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind CERO THERAPEUTICS HOLDINGS, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for CERO THERAPEUTICS HOLDINGS, INC.. With no account yet, you sign up free and land on the result.
On these lists: Pharmaceuticals raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/cero-therapeutics-holdings-inc-form-d-25000001